Price $5.05 |
Market Cap
336.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.24
|
P/S
189.85
|
Dividend %
-
|
|
P/CF
3.9
|
P/FCF
-
|
Op. Cash Flow
-46.6K
|
FCF
-1.0
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-28.50%
|
ROI
-26.50%
|
|
ROA
-26.40%
|
EPS Growth
60.10%
|
Current Ratio
18.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Opiant Pharmaceuticals Inc (OPNT) | $15.25 | - | - | 40.1M | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.00 | - | 4.30% | 180.1M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.70 | - | - | 87.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
| Pernix Therapeutics Holdings I (PTX) | $2.56 | - | - | 29M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
